Effects of Aspirin Usage
Common Side Effects
Aspirin is classified as a non-steroidal anti-inflammatory drug (NSAID) that helps alleviate pain and reduce fever associated with various conditions, such as colds and arthritis. It may also be prescribed by healthcare providers for the prevention of heart attacks and blood clots. It is important to note that aspirin is not recommended for children under the age of twelve without medical consultation. Moreover, there are several common side effects associated with the use of aspirin. Below are some of these effects:
- Nausea.
- Heartburn.
- Increased stomach acid production.
- Irritation of the stomach or intestines.
- Abdominal cramps.
Serious Side Effects
In addition to the common side effects, there are several serious side effects that warrant immediate medical attention, including:
- Hearing loss.
- Difficulty breathing or rapid breathing.
- Hoarseness.
- Swelling of the face, eyes, or tongue.
- Skin rash.
- Tinnitus (ringing in the ears).
- Vomiting blood.
- Presence of blood in stool.
- Increased heart rate.
Warnings for Aspirin Use
It is essential to inform your healthcare provider before using aspirin if you have any of the following conditions:
- Asthma.
- Liver or kidney disease.
- Peptic ulcers.
- Anemia.
- Frequent nasal congestion.
- Recurrent gastrointestinal disturbances.
- Gout.
- Diabetes.
- Hemophilia or any other bleeding disorders.
Contraindications for Aspirin Use
There are certain conditions where the use of aspirin is contraindicated. Some of these conditions include:
- Pregnant women, especially in the last trimester.
- Nursing mothers.
- Individuals with a known allergy to aspirin or those using NSAIDs.
References
- ↑ “Aspirin Tablet”, www.webmd.com, Retrieved 12-3-2019.
- ↑ “Aspirin Tablet Side Effects by Likelihood and Severity”, www.webmd.com, Retrieved 10-3-2019.
- ↑ Lynn Marks (3-3-2015), “What Is Aspirin?”, www.everydayhealth.com, Retrieved 12-3-2019.
- ^ Kristina Duda (20-1-2018), “Aspirin Facts and Concerns”, www.verywellhealth.com, Retrieved 12-3-2019.